Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases

ABOUT THIS EPISODE

Originally aired: May 1, 2026 

CHEST May 2026, Volume 169, Issue 5  

Valerie Dehondt, PharmD, and Lies Lahousse, PharmD, PhD, join CHEST^® Journal Podcast Moderator Gretchen Winter, MD, to discuss their research into the association between long-term proton pump inhibitor use and exacerbation risk in patients with chronic obstructive airway diseases.  

Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.      

Moderator
Gretchen Winter, MD 

Also available